Home Overview Press Room Blog Publications For Students about us
Search

Biotech & Pharma : Displaying 11-20 of 2367


Promising gene therapies pose million-dollar conundrumby Erika Check HaydenNature NewsJune 15th, 2016Economists, investors and medical insurers can’t figure out how to pay for gene therapy treatments.
Should We Sequence the DNA of Every Cancer Patient?by Antonio RegaladoMIT Technology ReviewJune 14th, 2016To match cancer patients with drugs, Strata Oncology plans to offer free genetic tests.
‘Safe’ call? My thoughts on the latest mitochondrial replacement paper by Ted MorrowTed's BlogJune 14th, 2016A paper published by Nature discusses mitochondrial replacement but underplays the danger of "mitonuclear mismatching."
Myriad Genetics Refuses To Accept That People Have A Right To Access Their Own DNA Sequencesby Glyn MoodyTech DirtJune 13th, 2016The fight for a patent over people's DNA sequences has been met with resistance by the US Supreme Court and the ACLU.
Are DIY gene-testing kits a good idea?​ by Sharon BrennanThe Guardian June 13th, 2016Over-the-counter tests can predict the likelihood of developing illnesses such as cancer and diabetes. However, they cause some people anxiety, as there are no cures for most hereditary conditions.
Now They’re Sequencing DNA in Outer Spaceby Antonio RegaladoMIT Technology ReviewJune 10th, 2016Eyeing eventual Mars mission, NASA plans first test of genetic diagnostics in space.
Better Mitochondrial Replacement: But Why? by Ricki LewisPLOSJune 9th, 2016Mitochondrial replacement raises questions around necessity and efficacy, as the relatively new process manipulates embryos.
The National Academies’ Gene Drive study has ignored important and obvious issues by Jim ThomasThe Guardian June 9th, 2016Some important gaps in the study include an analysis of militarization and commercialization, along with other possible consequences of gene drives.
Mitochondrial Replacement Hype Goes Nuclear Including by Wellcome Trustby Paul KnoepflerThe NicheJune 9th, 2016The risks of 3-person IVF are improperly accounted for amidst overblown optimism.
Big Biotech is here — and it’s starting to look a lot like Big Pharma by Meghana KeshavanSTAT NewsJune 6th, 2016The market characteristics and goals of biotech companies align increasingly with those of pharmaceutical companies.
Displaying 11-20 of 2367  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760